Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 155INDUSTRY 145NIH 26OTHER_GOV 2NETWORK 2INDIV 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1Genitourinary 1Gastrointestinal 1

Conditions

Urinary Bladder Neoplasms 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Lung Neoplasms 1Colorectal Neoplasms 1Adenocarcinoma 1

Interventions

Proflavine 4Microbial Collagenase 2sargramostim 1pembrolizumab 1pegfilgrastim 1macimorelin 1keyhole-limpet hemocyanin 1Sodium Chloride 1Sirolimus 1Peptides 1Monatide (IMS 3015) 1Ipilimumab 1Gemcitabine 1Everolimus 1Biological Products 1Bimatoprost 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × INDIV × Ipilimumab × Clear all
NCT03695835 2020-07-22

NIRPA

Gary Onik MD

Completed
27 enrolled
GastrointestinalGenitourinaryThoracic

Adenocarcinoma, Urinary Bladder Neoplasms, Lung Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡